Page 23 - LRCC July 2025 Focus
P. 23

Accelerating Innovation:

                                                          IONETIX Expansion Powers

                                                            Lansing’s MedTech Future


                                                                     By Katie Goble, Digital Marketing Intern, LEAP



















              he Lansing Region’s growing reputation as        “Delta Township and the Lansing region offer the ideal
              a hub for high-tech medical innovation has        environment for IONETIX’s continued growth,” said Kevin
        Tgained a powerful boost with IONETIX’s recent          J. Cameron, CEO of IONETIX. “The area’s highly skilled
        announcement of a major expansion at its Delta          workforce, robust infrastructure, and strong spirit of
        township facility located at 6424 Westland Way. The     public-private collaboration make it the perfect location
        advanced radiopharmaceutical company is investing       for our expansion.”
        $27.75 million to enhance its operations with a second
        superconducting cyclotron and a state-of-the-art isotope   With strong academic anchors like Michigan State
        processing laboratory—an expansion that is expected to   University, which holds the No. 2 national ranking in
        create 53 high-skill jobs in the region.                nuclear physics, and a thriving coalition of life sciences,
                                                                healthcare, and technology leaders through Michigan’s
        Founded in 2009 at MIT’s Plasma Science and Infusion    Health Core, the Lansing Region is rapidly emerging as a
        Center, IONETIX is renowned for their development of    national MedTech powerhouse.
        superconducting cyclotrons. The machines are essential
        for medical diagnostics, including targeted alpha       The project was awarded a $750,000 incentive from
        therapy (TAT)— a promising cancer treatment method      the Michigan Business Development Program, a
        that precisely targets tumors while sparing healthy     reflection of the strong presence of radiopharmaceutical
        tissues.                                                manufacturing to the state’s economy and innovation
                                                                ecosystem.
        “IONETIX’s expansion is creating high-value jobs and
        elevating the Lansing Region within the global medical   Thanks to the strategic partnership between IONETIX
        technology landscape,” said Bob Trezise, president and   and state and local organizations like Lansing
        CEO of the Lansing Economic Area Partnership (LEAP).    Economic Area Partnership (LEAP), Michigan Economic
        “LEAP is proud to support this project and the ecosystem   Development Corporation (MEDC), and Delta Township,
        of innovative MedTech companies making our region       we are ensuring a strong pipeline of skilled talent and
        a destination for biomedical research and economic      high-level job opportunities are maintained.
        opportunity.”
                                                                The IONETIX expansion is more than a business growth
        That spirit of innovation and opportunity was on full   story—it’s a reaffirmation that global innovation can and
        display at a recent community event held at the IONETIX   does thrive right here in Mid-Michigan.
        facility, where regional leaders and stakeholders
        gathered to celebrate the ribbon cutting of the facility   To learn more about the Lansing region’s growing
        expansion and additional cyclotron.                     MedTech hub, and our global push towards accessible
                                                                medical care, visit michiganshealthcore.com. u


                                                                                           lansingchamber.org     23
   18   19   20   21   22   23   24   25   26   27   28